MD Anderson Cancer Center led a new cell-based immunotherapy clinical trial demonstrated powerfully positive results for 11 patients with either chronic lymphocytic leukemia (CLL) or non-Hodgkin’s lymphoma (NHL) who had exhausted all other treatment options. The Study...